EuropeSouth AsiaAsia PacificAmericasMiddle EastAfricaBBC HomepageWorld ServiceEducation
News image
News image
News image
News imageNews image
News image
Front Page
News image
World
News image
UK
News image
UK Politics
News image
Business
News image
Sci/Tech
News image
Health
News image
Education
News image
Sport
News image
Entertainment
News image
Talking Point
News image
In Depth
News image
On Air
News image
Archive
News image
News image
News image
Feedback
Low Graphics
Help
News imageNews imageNews image
News imageWednesday, May 12, 1999 Published at 11:42 GMT 12:42 UK
News image
News image
Health
News image
Warning on Internet 'party drugs'
News image
The drugs are used recreationally
News image
Health supplements to aid sleep, which are advertised on the Internet as "party drugs", have been linked to three deaths, US health officials have said.

The Food and Drug Administration (FDA) said the drugs - which are related to so-called date rape drugs - are dangerous and advised people not to take them.

The FDA said products containing the drugs were widely available.

"These products are listed as 'party drugs' on Internet sites, advertised in muscle-building magazines, and sold in health food stores as dietary supplements to aid in sleep," it said.

"The FDA, however, considers these products unapproved new drugs and has conducted seizures of the product to prevent the sale to consumers and any further illnesses or deaths."

Health risks

The agency said three drugs - gamma butyrolactone (GBL) gamma hydroxzybutyric acid (GHB) and 1,4 butanediol (BD) - had been "associated with reports of at least 122 adverse health effects, including the three deaths".


[ image: ]
"In particular, one of these products, 1,4 butanediol (BD) has been declared a Class I Health Hazard - a potentially life-threatening risk - by the FDA," it said.

"BD is a chemical that can cause dangerously low respiratory rates, unconsciousness, vomiting, seizures and death. BD may also increase the effects of alcohol and is even more dangerous when consumed with other depressant drugs."

GHB is also known as liquid X or g-juice, and was once sold in health food stores to bodybuilders. It was pulled off the market in 1990 because of its bad side effects.

Along with another drug - Rohypnol - GHB has been associated with several date rape cases.

Drug causes confusion

The effects of GHB are similar to those of Rohypnol - dizziness, confusion and memory loss.

Instructions on how to make the drug are available on the Internet, and in January the FDA urged Congress to impose harsher restrictions on it.

But campaigners say the drug is safe and effective, both for treating sleep disorders and as a recreational drug.

They say the FDA and the US Drugs Enforcement Agency are trying to mislead the public on the drug's benefits.

GBL is not illegal, but drug agencies would like to see it outlawed. Drug companies are resisting any such move as they want to investigate the compounds' medicinal properties.

Chiropractor jailed for distributing drug

In February last year a Los Angeles chiropractor was fined $2,000 and jailed for illegally distributing drinks containing BD at a New Year's Eve 1996 party, the FDA said.

The drinks were blamed for making more than 100 party-goers ill.

"The FDA warned consumers not to ingest the products blamed for the injuries, which were labeled Cherry fX Bombs, Lemon fX Drops and Orange fX Rush. They all contained 1,4 butanediol," the agency said.

News image


Advanced options | Search tips


News image
News image
News imageBack to top | BBC News Home | BBC Homepage |
News image

News imageNews imageNews image
Health Contents
News image
News imageBackground Briefings
News imageMedical notes
News imageNews image
Relevant Stories
News image
02 Feb 99�|�Medical notes
Rohypnol: The date rape drug
News image

News image
News image
News image
News imageInternet Links
News image
News imageNews image
GHB Forum
News image
Cognitive Enhancement Research Institute
News image
News imageNews image
The BBC is not responsible for the content of external internet sites.

News image
News image
News image
News imageIn this section
News image
Disability in depth
News image
Spotlight: Bristol inquiry
News image
Antibiotics: A fading wonder
News image
Mental health: An overview
News image
Alternative medicine: A growth industry
News image
The meningitis files
News image
Long-term care: A special report
News image
Aids up close
News image
From cradle to grave
News image
NHS reforms: A guide
News image
NHS Performance 1999
News image
From Special Report
NHS in crisis: Special report
News image
British Medical Association conference '99
News image
Royal College of Nursing conference '99
News image

News image
News image
News image